Boulware, David R.
University of Minnesota
19 papers on CoChatORCID 0000-0002-4715-0060
Most cited papers
- Verified
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases
Fungal Infections and StudiesInfectious Diseases and Tuberculosis
Cited by 1,861
- Verified
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study
Bahr, N. C., Nuwagira, E., Evans, E. E., Cresswell, F. V., Bystrom, P. V., Byamukama, A., Bridge, S. C., Bangdiwala, A. S., Meya, D. B., Denkinger, C. M., et al. (2018) · The Lancet Infectious Diseases
Infectious Diseases and TuberculosisTuberculosis Research and Epidemiology
Cited by 308
- Verified
Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19.
Bramante, C. T., Huling, J. D., Tignanelli, C. J., Buse, J. B., Liebovitz, D. M., Nicklas, J. M., Cohen, K., Puskarich, M. A., Belani, H. K., Proper, J. L., et al. (2022) · New England Journal of Medicine
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 242
- Verified
Chitin Recognition via Chitotriosidase Promotes Pathologic Type-2 Helper T Cell Responses to Cryptococcal Infection
Wiesner, D. L., Specht, C. A., Lee, C. K., Smith, K. D., Mukaremera, L., Lee, S. T., Lee, C. G., Elias, J. A., Nielsen, J. N., Boulware, D. R., et al. (2015) · PLOS Pathogens
Fungal Infections and StudiesStudies on Chitinases and Chitosanases
Cited by 214
- Verified
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: An open-label dose-ranging study
Rhein, J., Morawski, B. M., Hullsiek, K. H., Nabeta, H. W., Kiggundu, R., Tugume, L., Musubire, A., Akampurira, A., Smith, K. D., Alhadab, A., et al. (2016) · The Lancet Infectious Diseases
Fungal Infections and StudiesInfectious Diseases and Tuberculosis
Cited by 183
- Verified
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study
Cresswell, F. V., Tugume, L., Bahr, N. C., Kwizera, R., Bangdiwala, A. S., Musubire, A. K., Rutakingirwa, M., Kagimu, E., Nuwagira, E., Mpoza, E., et al. (2020) · The Lancet Infectious Diseases
Infectious Diseases and TuberculosisTuberculosis Research and Epidemiology
Cited by 124
- Verified
Methods for Rapid Diagnosis of Meningitis Etiology in Adults
Poplin, V., Boulware, D. R., & Bahr, N. C. (2020) · Biomarkers in Medicine
Bacterial Infections and VaccinesBacterial Identification and Susceptibility Testing
Cited by 119
- Verified
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
Loyse, A., Burry, J., Cohn, J., Ford, N., Chiller, T., Ribeiro, I., Koulla-Shiro, S., Mghamba, J., Ramadhani, A., Nyirenda, R., et al. (2019) · The Lancet Infectious Diseases
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 90
- Verified
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial
Naggie, S., Boulware, D. R., Lindsell, C. J., Stewart, T. G., Slandzicki, A. J., Lim, S. C., Cohen, J., Kavtaradze, D., Amon, A. P., Gabriel, A., et al. (2023) · JAMA
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 79
- Verified
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Skipper, C. P., Atukunda, M., Stadelman, A., Engen, N. W., Bangdiwala, A. S., Hullsiek, K. H., Abassi, M., Rhein, J., Nicol, M. R., Laker, E., et al. (2020) · Antimicrobial Agents and Chemotherapy
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 60
- Verified · note
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
Meya, D. B., Kiragga, A. N., Nalintya, E., Morawski, B. M., Rajasingham, R., Park, B. J., Mubiru, A., Kaplan, J. E., Manabe, Y. C., Boulware, D. R., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes
Fungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment
Cited by 47
- Verified
Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis.
Alpern, J. D., Bahr, N. C., Vazquez-Benitez, G., Boulware, D. R., Sellman, J. S., & Sarosi, G. A. (2016) · Open Forum Infectious Diseases
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 42
- Verified
Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population
Bridge, S., Hullsiek, K. H., Nerima, C., Evans, E. E., Nuwagira, E., Stadelman, A. M., Tran, T., Kim, G., Tadeo, K. K., Kwizera, R., et al. (2021) · Journal of Medical Mycology
Bacterial Infections and VaccinesInfectious Encephalopathies and Encephalitis
Cited by 38
- Verified
Hydroxychloroquine for COVID19: the curtains close on a comedy of errors
Schwartz, I. S., Boulware, D. R., & Lee, T. C. (2022) · The Lancet Regional Health - Americas
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 37
- Verified
Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality
Musubire, A. K., Meya, D. B., Rhein, J., Meintjes, G., Bohjanen, P. R., Nuwagira, E., Muzoora, C., Boulware, D. R., Hullsiek, K. H., & teams, T. C. A. A. T. (2018) · PLOS ONE
Fungal Infections and StudiesInfectious Diseases and Tuberculosis
Cited by 27
- Verified
Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs
Nielsen, K., Vedula, P., Smith, K. D., Meya, D. B., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., & Boulware, D. R. (2016) · Medical Mycology
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 24
- Verified
ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50
Gerlach, E. S., Altamirano, S., Yoder, J. M., Luggya, T. S., Akampurira, A., Meya, D. B., Boulware, D. R., Rhein, J., & Nielsen, K. (2021) · Frontiers in Cellular and Infection Microbiology
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 17
- Verified
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial
Bramante, C. T., Stewart, T. G., Boulware, D. R., McCarthy, M. W., Gao, Y., Rothman, R. L., Mourad, A., Thicklin, F., Cohen, J. B., Garcia del Sol, I. T., et al. (2025) · JAMA Internal Medicine
COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Cited by 8
- Verified
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial
Bramante, C. T., Stewart, T. G., Boulware, D. R., McCarthy, M. W., Gao, Y., Rothman, R. L., Mourad, A., Thicklin, F., Cohen, J. B., Garcia del Sol, I. T., et al. (2025) · JAMA Internal Medicine
COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free